DE602005018969D1 - Zusammensetzungen mit Antimuskarin-Wirkstoffen und Corticosteroiden - Google Patents

Zusammensetzungen mit Antimuskarin-Wirkstoffen und Corticosteroiden

Info

Publication number: DE602005018969D1
Authority: DE; Germany
Prior art keywords: corticosteroids; compositions; antimuscarinic agents; anion; azoniabicyclo
Prior art date: 2004-05-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

DE602005018969T

Other languages

English (en)

Inventor

Escardo Jordi Gras

Calvo Jesus Llenas

Hamish Ryder

Diaz Pio Orviz

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Almirall SA

Original Assignee

Almirall SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-31

Filing date

2005-05-31

Publication date

2010-03-04

2004-05-31 Priority claimed from ES200401312A external-priority patent/ES2257152B1/es

2005-05-31 Application filed by Almirall SA filed Critical Almirall SA

2010-03-04 Publication of DE602005018969D1 publication Critical patent/DE602005018969D1/de

Status Active legal-status Critical Current

2025-06-01 Anticipated expiration legal-status Critical

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

DE602005018969T 2004-05-31 2005-05-31 Zusammensetzungen mit Antimuskarin-Wirkstoffen und Corticosteroiden Active DE602005018969D1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
ES200401312A ES2257152B1 (es)	2004-05-31	2004-05-31	Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
EP2005001969		2005-02-24
GB2005000722		2005-02-25
GB2005000740		2005-02-25

Publications (1)

Publication Number	Publication Date
DE602005018969D1 true DE602005018969D1 (de)	2010-03-04

Family

ID=34968792

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DE602005018969T Active DE602005018969D1 (de)	2004-05-31	2005-05-31	Zusammensetzungen mit Antimuskarin-Wirkstoffen und Corticosteroiden
DE602005022499T Active DE602005022499D1 (de)	2004-05-31	2005-05-31	Kombinationen mit Antimuskarin-Wirkstoffen und PDE4-Hemmern
DE602005012102T Active DE602005012102D1 (de)	2004-05-31	2005-05-31	Kombinationen aus antimuscarinischen mitteln und beta-adrenergen agonisten

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DE602005022499T Active DE602005022499D1 (de)	2004-05-31	2005-05-31	Kombinationen mit Antimuskarin-Wirkstoffen und PDE4-Hemmern
DE602005012102T Active DE602005012102D1 (de)	2004-05-31	2005-05-31	Kombinationen aus antimuscarinischen mitteln und beta-adrenergen agonisten

Country Status (21)

Country	Link
US (2)	US20110224177A1 (de)
EP (5)	EP1891974B1 (de)
JP (1)	JP2012211183A (de)
AT (3)	ATE474601T1 (de)
AU (3)	AU2005247104B2 (de)
CA (3)	CA2568571C (de)
CY (1)	CY1110829T1 (de)
DE (3)	DE602005018969D1 (de)
DK (2)	DK1891974T3 (de)
ES (2)	ES2317245T3 (de)
HK (1)	HK1096605A1 (de)
HR (3)	HRP20090106T3 (de)
IL (3)	IL179685A (de)
MX (3)	MXPA06013849A (de)
NZ (3)	NZ551670A (de)
PL (2)	PL1905451T3 (de)
PT (3)	PT1905451E (de)
RS (3)	RS51206B (de)
RU (3)	RU2404772C2 (de)
SI (3)	SI1765404T1 (de)
WO (3)	WO2005115465A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2165768B1 (es)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
WO2006085689A1 (ja) *	2005-02-10	2006-08-17	Oncolys Biopharma, Inc.	テロメライシン併用抗癌剤
MX2009008794A (es) *	2007-02-19	2009-08-25	Cipla Ltd	Combinaciones farmaceuticas al menos de dos broncodilatadores o de un broncodilatador con un corticosteroide.
EP2080523A1 (de) *	2008-01-15	2009-07-22	CHIESI FARMACEUTICI S.p.A.	Zusammensetzungen mit einem antimuskarinischen und einem langwirksamen Beta-Agonisten
EP2080508A1 (de) *	2008-01-15	2009-07-22	CHIESI FARMACEUTICI S.p.A.	Trockenpulverformulierung mit einem anticholinergischen Arzneimittel
EP2100599A1 (de)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100598A1 (de)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
GB0811100D0 (en) *	2008-06-17	2008-07-23	Astrazeneca Ab	New combination
GB0814728D0 (en) *	2008-08-12	2008-09-17	Argenta Discovery Ltd	New combination
EP2400950B1 (de)	2009-02-26	2019-05-22	Glaxo Group Limited	Pharmazeutische formulierungen enthaltend 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
WO2010097114A1 (en) *	2009-02-26	2010-09-02	Glaxo Group Limited	Novel combination of therapeutic agents
CN107722036B (zh)	2009-05-14	2020-09-04	天津合美医药科技有限公司	噻吩衍生物
GB0921075D0 (en) *	2009-12-01	2010-01-13	Glaxo Group Ltd	Novel combination of the therapeutic agents
EP2510928A1 (de)	2011-04-15	2012-10-17	Almirall, S.A.	Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
EP2836204B1 (de)	2012-04-13	2020-07-08	GlaxoSmithKline Intellectual Property Development Limited	Aggregatteilchen
GB201222679D0 (en)	2012-12-17	2013-01-30	Glaxo Group Ltd	Pharmaceutical combination products
EP2968313B1 (de) *	2013-03-15	2018-01-31	Verona Pharma PLC	Arzneimittelkombination
GB201308933D0 (en) *	2013-05-17	2013-07-03	Diurnal Ltd	Paediatric composition
CA2917320C (en) *	2013-07-05	2020-10-13	Bioneer Corporation	Respiratory disease-related gene specific sirna, double-helical oligo rna structure containing sirna, composition containing same for preventing or treating respiratory disease
TW201542207A (zh) *	2013-10-03	2015-11-16	Otsuka Pharma Co Ltd	嚴重氣喘治療劑

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT7920688V0 (it)	1979-02-05	1979-02-05	Chiesi Paolo Parma	Inalatore per sostanze medicamentose pulverulente, con combinata funzione di dosatore.
DE3274065D1 (de)	1981-07-08	1986-12-11	Draco Ab	Powder inhalator
US4570630A (en)	1983-08-03	1986-02-18	Miles Laboratories, Inc.	Medicament inhalation device
FI69963C (fi)	1984-10-04	1986-09-12	Orion Yhtymae Oy	Doseringsanordning
DE3927170A1 (de)	1989-08-17	1991-02-21	Boehringer Ingelheim Kg	Inhalator
IT1237118B (it)	1989-10-27	1993-05-18	Miat Spa	Inalatore multidose per farmaci in polvere.
US5201308A (en)	1990-02-14	1993-04-13	Newhouse Michael T	Powder inhaler
GB9004781D0 (en)	1990-03-02	1990-04-25	Glaxo Group Ltd	Device
SG45171A1 (en)	1990-03-21	1998-01-16	Boehringer Ingelheim Int	Atomising devices and methods
GB9015522D0 (en)	1990-07-13	1990-08-29	Braithwaite Philip W	Inhaler
WO1992003175A1 (en)	1990-08-11	1992-03-05	Fisons Plc	Inhalation device
DE4027391A1 (de)	1990-08-30	1992-03-12	Boehringer Ingelheim Kg	Treibgasfreies inhalationsgeraet
EP0640354B1 (de)	1990-09-26	2001-12-05	Pharmachemie B.V.	Wirbelkammer-Pulverinhalator
GB9026025D0 (en)	1990-11-29	1991-01-16	Boehringer Ingelheim Kg	Inhalation device
AU650953B2 (en)	1991-03-21	1994-07-07	Novartis Ag	Inhaler
DE4239402A1 (de)	1992-11-24	1994-05-26	Bayer Ag	Pulverinhalator
MY115140A (en)	1992-12-18	2003-04-30	Schering Corp	Inhaler for powdered medications
US5837699A (en) *	1994-01-27	1998-11-17	Schering Corporation	Use of mometasone furoate for treating upper airway passage diseases
BR9604977A (pt)	1995-04-14	1998-06-09	Glaxo Wellcome Inc	Inalador de dose medida sistema inalador de dose medida e uso do mesmo
HU220227B (hu)	1995-06-21	2001-11-28	Asta Medica A.G.	Gyógyszerporos patron integrált adagolószerkezettel és inhalálókészülék poralakú gyógyszerekhez
DE19536902A1 (de)	1995-10-04	1997-04-10	Boehringer Ingelheim Int	Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
ES2165768B1 (es) *	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB0009592D0 (en)	2000-04-18	2000-06-07	Glaxo Group Ltd	Respiratory combinations
GB0009605D0 (en)	2000-04-18	2000-06-07	Glaxo Group Ltd	Medicaments
GB0009583D0 (en)	2000-04-18	2000-06-07	Glaxo Group Ltd	Respiratory formulations
GB0009606D0 (en)	2000-04-18	2000-06-07	Glaxo Group Ltd	Therapeutic combinations
EP1318973A2 (de) *	2000-09-22	2003-06-18	Glaxo Group Limited	Neue alkansäurederivate
WO2002036106A2 (de)	2000-10-31	2002-05-10	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue arzneimittelkompositionen auf der basis von anticholingergika und corticosteroiden
DE10062712A1 (de)	2000-12-15	2002-06-20	Boehringer Ingelheim Pharma	Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
DE10056104A1 (de) *	2000-11-13	2002-05-23	Boehringer Ingelheim Pharma	Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols
CN1250545C (zh) *	2000-12-28	2006-04-12	阿尔米雷尔普罗迪斯制药有限公司	新的奎宁环衍生物类及含有这类衍生物的药物组合物
ATE347361T1 (de) *	2001-05-25	2006-12-15	Boehringer Ingelheim Pharma	Kombination eines pde4-inhibitors mit tiotropium zur behandlung obstruktiver atemwegserkrankungen
DE10130371A1 (de) *	2001-06-23	2003-01-02	Boehringer Ingelheim Pharma	Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
ES2206021B1 (es) *	2002-04-16	2005-08-01	Almirall Prodesfarma, S.A.	Nuevos derivados de pirrolidinio.
ES2195785B1 (es)	2002-05-16	2005-03-16	Almirall Prodesfarma, S.A.	Nuevos derivados de piridazin-3(2h)-ona.
ES2211315B1 (es)	2002-11-12	2005-10-16	Almirall Prodesfarma, S.A.	Nuevos compuestos triciclicos.
ES2211344B1 (es)	2002-12-26	2005-10-01	Almirall Prodesfarma, S.A.	Nuevos derivados de piridazin-3(2h)-ona.
PE20040950A1 (es) *	2003-02-14	2005-01-01	Theravance Inc	DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
CA2519682A1 (en) *	2003-03-28	2004-10-07	Altana Pharma Ag	Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
CA2519679C (en) *	2003-03-28	2012-08-28	Altana Pharma Ag	Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
ES2257152B1 (es) *	2004-05-31	2007-07-01	Laboratorios Almirall S.A.	Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.

2005
- 2005-05-31 CA CA2568571A patent/CA2568571C/en not_active Expired - Fee Related
- 2005-05-31 RS RSP-2010/0104A patent/RS51206B/sr unknown
- 2005-05-31 EP EP07019646A patent/EP1891974B1/de active Active
- 2005-05-31 NZ NZ551670A patent/NZ551670A/en not_active IP Right Cessation
- 2005-05-31 EP EP05746222A patent/EP1761279A1/de not_active Withdrawn
- 2005-05-31 EP EP10003385A patent/EP2210614A1/de not_active Withdrawn
- 2005-05-31 SI SI200530599T patent/SI1765404T1/sl unknown
- 2005-05-31 DE DE602005018969T patent/DE602005018969D1/de active Active
- 2005-05-31 RU RU2006147269/15A patent/RU2404772C2/ru not_active IP Right Cessation
- 2005-05-31 RS RSP-2010/0379A patent/RS51422B/en unknown
- 2005-05-31 RU RU2006146813/15A patent/RU2385156C2/ru not_active IP Right Cessation
- 2005-05-31 ES ES05748688T patent/ES2317245T3/es active Active
- 2005-05-31 DE DE602005022499T patent/DE602005022499D1/de active Active
- 2005-05-31 AT AT07019646T patent/ATE474601T1/de active
- 2005-05-31 ES ES07023760T patent/ES2336144T3/es active Active
- 2005-05-31 NZ NZ551669A patent/NZ551669A/en not_active IP Right Cessation
- 2005-05-31 PT PT07023760T patent/PT1905451E/pt unknown
- 2005-05-31 CA CA2569074A patent/CA2569074C/en not_active Expired - Fee Related
- 2005-05-31 AU AU2005247104A patent/AU2005247104B2/en not_active Ceased
- 2005-05-31 WO PCT/EP2005/005839 patent/WO2005115465A1/en not_active Application Discontinuation
- 2005-05-31 SI SI200530959T patent/SI1905451T1/sl unknown
- 2005-05-31 EP EP05759006A patent/EP1765405A1/de not_active Withdrawn
- 2005-05-31 WO PCT/EP2005/005837 patent/WO2005115463A1/en active Application Filing
- 2005-05-31 WO PCT/EP2005/005838 patent/WO2005115464A1/en not_active Application Discontinuation
- 2005-05-31 AU AU2005247106A patent/AU2005247106B2/en not_active Ceased
- 2005-05-31 PT PT07019646T patent/PT1891974E/pt unknown
- 2005-05-31 AT AT07023760T patent/ATE454904T1/de active
- 2005-05-31 MX MXPA06013849A patent/MXPA06013849A/es active IP Right Grant
- 2005-05-31 PL PL07023760T patent/PL1905451T3/pl unknown
- 2005-05-31 EP EP07023760A patent/EP1905451B1/de active Active
- 2005-05-31 RU RU2006146673/15A patent/RU2379033C2/ru not_active IP Right Cessation
- 2005-05-31 DE DE602005012102T patent/DE602005012102D1/de active Active
- 2005-05-31 AU AU2005247105A patent/AU2005247105B2/en not_active Ceased
- 2005-05-31 AT AT05748688T patent/ATE419011T1/de active
- 2005-05-31 CA CA2568568A patent/CA2568568C/en not_active Expired - Fee Related
- 2005-05-31 MX MXPA06013846A patent/MXPA06013846A/es active IP Right Grant
- 2005-05-31 RS RSP-2009/0075A patent/RS50786B/sr unknown
- 2005-05-31 MX MXPA06013850A patent/MXPA06013850A/es active IP Right Grant
- 2005-05-31 DK DK07019646.4T patent/DK1891974T3/da active
- 2005-05-31 PT PT05748688T patent/PT1765404E/pt unknown
- 2005-05-31 DK DK07023760.7T patent/DK1905451T3/da active
- 2005-05-31 SI SI200531128T patent/SI1891974T1/sl unknown
- 2005-05-31 NZ NZ551666A patent/NZ551666A/en not_active IP Right Cessation
- 2005-05-31 PL PL07019646T patent/PL1891974T3/pl unknown
2006
- 2006-11-29 IL IL179685A patent/IL179685A/en not_active IP Right Cessation
- 2006-11-29 IL IL179686A patent/IL179686A0/en unknown
- 2006-11-29 IL IL179690A patent/IL179690A/en not_active IP Right Cessation
2007
- 2007-04-03 HK HK07103580.3A patent/HK1096605A1/xx not_active IP Right Cessation
2009
- 2009-02-20 HR HR20090106T patent/HRP20090106T3/xx unknown
2010
- 2010-02-26 HR HR20100104T patent/HRP20100104T1/hr unknown
- 2010-09-03 HR HR20100490T patent/HRP20100490T1/hr unknown
- 2010-10-11 CY CY20101100905T patent/CY1110829T1/el unknown
2011
- 2011-03-14 US US13/047,039 patent/US20110224177A1/en not_active Abandoned
2012
- 2012-07-06 JP JP2012152730A patent/JP2012211183A/ja active Pending
- 2012-09-05 US US13/603,985 patent/US20130196961A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ES2317245T3 (es)	2009-04-16
AU2005247106A1 (en)	2005-12-08
RS50786B (sr)	2010-08-31
PL1905451T3 (pl)	2010-05-31
US20110224177A1 (en)	2011-09-15
EP1905451B1 (de)	2010-01-13
AU2005247104B2 (en)	2010-11-11
EP2210614A1 (de)	2010-07-28
PT1765404E (pt)	2009-03-31
NZ551669A (en)	2010-07-30
RU2385156C2 (ru)	2010-03-27
PL1891974T3 (pl)	2010-12-31
ES2336144T3 (es)	2010-04-08
NZ551666A (en)	2010-07-30
AU2005247104A1 (en)	2005-12-08
RU2006146673A (ru)	2008-07-20
IL179685A (en)	2012-01-31
EP1891974B1 (de)	2010-07-21
RS51206B (sr)	2010-12-31
IL179686A0 (en)	2007-05-15
CA2568571A1 (en)	2005-12-08
AU2005247105A1 (en)	2005-12-08
SI1905451T1 (sl)	2010-05-31
CA2569074A1 (en)	2005-12-08
WO2005115464A1 (en)	2005-12-08
WO2005115463A1 (en)	2005-12-08
EP1761279A1 (de)	2007-03-14
SI1765404T1 (sl)	2009-04-30
EP1905451A1 (de)	2008-04-02
RU2404772C2 (ru)	2010-11-27
HRP20100104T1 (hr)	2010-04-30
EP1891974A1 (de)	2008-02-27
CA2568568A1 (en)	2005-12-08
HK1096605A1 (en)	2007-06-08
CA2568568C (en)	2012-12-18
DE602005022499D1 (de)	2010-09-02
JP2012211183A (ja)	2012-11-01
DE602005012102D1 (de)	2009-02-12
IL179685A0 (en)	2007-05-15
SI1891974T1 (sl)	2010-11-30
US20130196961A1 (en)	2013-08-01
CA2568571C (en)	2012-12-18
AU2005247105B2 (en)	2010-11-11
EP1765405A1 (de)	2007-03-28
IL179690A (en)	2012-10-31
ATE419011T1 (de)	2009-01-15
PT1891974E (pt)	2010-09-27
IL179690A0 (en)	2007-05-15
MXPA06013849A (es)	2007-03-01
RU2379033C2 (ru)	2010-01-20
ATE454904T1 (de)	2010-01-15
RU2006146813A (ru)	2008-07-20
NZ551670A (en)	2010-07-30
CY1110829T1 (el)	2015-06-10
AU2005247106B2 (en)	2010-11-11
CA2569074C (en)	2012-12-18
DK1891974T3 (da)	2010-11-08
ATE474601T1 (de)	2010-08-15
MXPA06013846A (es)	2007-03-01
RU2006147269A (ru)	2008-07-20
PT1905451E (pt)	2010-03-31
MXPA06013850A (es)	2007-03-02
RS51422B (en)	2011-02-28
HRP20100490T1 (hr)	2010-10-31
WO2005115465A1 (en)	2005-12-08
HRP20090106T3 (en)	2009-03-31
DK1905451T3 (da)	2010-05-10

Legal Events

Date	Code	Title	Description
2011-02-03	8364	No opposition during term of opposition